![](https://framerusercontent.com/images/BJQ4neYMS0o2LGUTuGvY8HnHYh4.png)
Research
Psychedelic-Assisted Psychotherapy: Revolutionizing Mental Health Treatment
Psychedelic-Assisted Psychotherapy (PAP) emerges as a groundbreaking approach in psychiatric research, offering promising results in treating various mental health conditions. This paradigm shift focuses on using substances like ketamine, MDMA, and psilocybin within comprehensive psychotherapy programs. Demonstrating significant efficacy even in treatment-resistant cases, PAP challenges traditional psychiatric models, incorporating biopsychosocial factors and non-ordinary states of consciousness into treatment. This innovative method could reshape our understanding and approach to mental health therapy.
Studies & Research
![](https://framerusercontent.com/images/wyUI117hBYDpnpuWzWCnjcQC73E.png)
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
![](https://framerusercontent.com/images/Jyl6P7n9iZ0vPihEEsj2dEf2Ka0.png)
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
![](https://framerusercontent.com/images/oUJjSb7aU5ciqJJ4Zos0YdXOg.png)
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
![](https://framerusercontent.com/images/9ftcLHcRSlKvcSNySKrYsQTuXA.png)
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
![](https://framerusercontent.com/images/ZF3uEXjYbQrGS4FhVQxqgRhWJao.png)
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
![](https://framerusercontent.com/images/PgegMmZhhbLp9xr12Z2XuIfuRME.png)
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
![](https://framerusercontent.com/images/e9rUdQlxTQQy9FdwWyA5HNBDuw.png)
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
![](https://framerusercontent.com/images/Ir9HIfcPvinG5HwZWgFOlMi5RpY.png)
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy
![](https://framerusercontent.com/images/BJQ4neYMS0o2LGUTuGvY8HnHYh4.png)
Research
Psychedelic-Assisted Psychotherapy: Revolutionizing Mental Health Treatment
Psychedelic-Assisted Psychotherapy (PAP) emerges as a groundbreaking approach in psychiatric research, offering promising results in treating various mental health conditions. This paradigm shift focuses on using substances like ketamine, MDMA, and psilocybin within comprehensive psychotherapy programs. Demonstrating significant efficacy even in treatment-resistant cases, PAP challenges traditional psychiatric models, incorporating biopsychosocial factors and non-ordinary states of consciousness into treatment. This innovative method could reshape our understanding and approach to mental health therapy.
Studies & Research
![](https://framerusercontent.com/images/wyUI117hBYDpnpuWzWCnjcQC73E.png)
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
![](https://framerusercontent.com/images/Jyl6P7n9iZ0vPihEEsj2dEf2Ka0.png)
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
![](https://framerusercontent.com/images/oUJjSb7aU5ciqJJ4Zos0YdXOg.png)
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
![](https://framerusercontent.com/images/9ftcLHcRSlKvcSNySKrYsQTuXA.png)
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
![](https://framerusercontent.com/images/ZF3uEXjYbQrGS4FhVQxqgRhWJao.png)
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
![](https://framerusercontent.com/images/PgegMmZhhbLp9xr12Z2XuIfuRME.png)
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
![](https://framerusercontent.com/images/e9rUdQlxTQQy9FdwWyA5HNBDuw.png)
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy